Package 65862-421-30

{"route": ["ORAL"], "spl_id": "ab772f55-3f84-41df-a84f-3a7035602cfd", "openfda": {"upc": ["0365862820303", "0365862819307"], "unii": ["OTT9J7900I"], "rxcui": ["349251", "1243227", "1243324", "1243328"], "spl_set_id": ["a75c6be8-3719-4bb3-8a9e-06e5254d2a82"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (65862-421-30)", "package_ndc": "65862-421-30", "marketing_start_date": "20180126"}], "brand_name": "Tenofovir Disoproxil Fumarate", "product_id": "65862-421_ab772f55-3f84-41df-a84f-3a7035602cfd", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]"], "product_ndc": "65862-421", "generic_name": "Tenofovir Disoproxil Fumarate", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tenofovir Disoproxil Fumarate", "active_ingredients": [{"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "300 mg/1"}], "application_number": "ANDA090647", "marketing_category": "ANDA", "marketing_start_date": "20180126", "listing_expiration_date": "20261231"}